Cargando…

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients

BACKGROUND: Technological advances in colon cancer treatment have significantly increased survival outcomes among metastatic patients. With different chemotherapy and biologic regimens administered in first, second, and subsequent lines of treatments, costs and survival outcomes vary considerably. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woldemichael, Andinet, Onukwugha, Eberechukwu, Seal, Brian, Hanna, Nader, Mullins, C. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397877/ https://www.ncbi.nlm.nih.gov/pubmed/27231791 http://dx.doi.org/10.18553/jmcp.2016.22.6.628

Ejemplares similares

Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
por: Zheng, Zhiyuan, et al.
Publicado: (2014)

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients
por: Reese, Emily S, et al.
Publicado: (2013)

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients
por: Zheng, Zhiyuan, et al.
Publicado: (2014)

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
por: Onukwugha, Eberechukwu, et al.
Publicado: (2014)

Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer
por: Hussain, Arif, et al.
Publicado: (2018)

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone
por: Onukwugha, Eberechukwu, et al.
Publicado: (2017)

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis
por: Onukwugha, Eberechukwu
Publicado: (2016)

Valuing diversity in value assessment: introducing the PhRMA Foundation Health Disparities Challenge Award
por: Onukwugha, Eberechukwu
Publicado: (2021)

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
por: Hussain, Arif, et al.
Publicado: (2016)

Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk
por: Onwudiwe, Nneka C, et al.
Publicado: (2014)

Why the Gap in Evaluating the Social Constructs and the Value of Medicines?
por: McRae, Jacquelyn, et al.
Publicado: (2021)

A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting
por: Onukwugha, Eberechukwu, et al.
Publicado: (2012)

The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoon Duk, et al.
Publicado: (2020)

Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods
por: Aly, Abdalla, et al.
Publicado: (2015)

Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer
por: Seal, Brian S., et al.
Publicado: (2016)

Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States
por: Jayasekera, Jinani, et al.
Publicado: (2019)

A Sustainable Strategy to Prevent Misuse of Antibiotics for Acute Respiratory Infections
por: Rattinger, Gail B., et al.
Publicado: (2012)

An ecological approach to monitor geographic disparities in cancer outcomes
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
por: Goto, Daisuke, et al.
Publicado: (2019)

Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
por: Park, Siyeon, et al.
Publicado: (2019)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
por: Richardson, Michael T., et al.
Publicado: (2023)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

A sequentially metastatic gastric and jejunal cancer originating from colon cancer: A case report
por: Lee, Woo Yong, et al.
Publicado: (2020)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

A low-cost wearable device for portable sequential compression therapy
por: Schara, Mark, et al.
Publicado: (2022)

Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
por: Yoshioka, T, et al.
Publicado: (2009)

Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer
por: Yanai, Keiko, et al.
Publicado: (2020)

The economic burden of Parkinson disease among Medicare beneficiaries
por: Albarmawi, Husam, et al.
Publicado: (2022)

Triptans for Migraine Therapy: A Comparison Based on Number Needed to Treat and Doses Needed to Treat
por: Mullins, C. Daniel
Publicado: (2005)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Metastatic Gastric Cancer to the Colon
por: Then, Eric Omar, et al.
Publicado: (2021)

Sequential Metastatic Breast Cancer Chemotherapy: Should the Median be the Message?
por: Jung, Su Yon, et al.
Publicado: (2013)

Sequential deconstruction of composite drug transport in metastatic breast cancer
por: Goel, Shreya, et al.
Publicado: (2020)

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
por: Xia, Chang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o09hqguek0893bjh1k4o47k90n